Skip to Main Content

Advertisement

Skip Nav Destination

A prospectively planned pathology study within the TEAM trial confirms that progesterone receptor expression is prognostic but is not predictive for differential response to exemestane versus tamoxifen.

Cancer Res (2009) 69 (2_Supplement): 81.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Cornelis JH van de Velde
  • Daniel Rea
  • Caroline Seynaeve
  • Hein Putter
  • Annette Hasenburg
  • Jean-Michel Vannetzel
  • Robert Paridaens
  • Christos Markopoulos
  • Yasuo Hozumi
  • Elysee TM Hille
  • Dirk G Kieback
  • Lina Asmar
  • Jan Smeets
  • Johan WR Nortier
  • Peyman Hadji
  • John MS Bartlett
  • Stephen E Jones
The Lancet (2011) 377 (9762): 321.
  • C.J.H. van de Velde
  • S. Verma
  • J.G.H. van Nes
  • C. Masterman
  • K.I. Pritchard
Cancer Treatment Reviews (2010) 36 (1): 54.
Close Modal

or Create an Account

Close Modal
Close Modal